Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP368757.RABrCyU9yAZIA_aVxu0MzsKKiU9ftfmQGqwwvT9ZY5gBE130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP368757.RABrCyU9yAZIA_aVxu0MzsKKiU9ftfmQGqwwvT9ZY5gBE130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP368757.RABrCyU9yAZIA_aVxu0MzsKKiU9ftfmQGqwwvT9ZY5gBE130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP368757.RABrCyU9yAZIA_aVxu0MzsKKiU9ftfmQGqwwvT9ZY5gBE130_provenance.
- NP368757.RABrCyU9yAZIA_aVxu0MzsKKiU9ftfmQGqwwvT9ZY5gBE130_assertion description "[Intrahepatic cholangiocarcinomas with chronic advanced liver disease showed higher EGFR mutation rate (5/38, 13.2% vs 1/43, 2.3%) and lower mutation rates of KRAS (3/38, 7.9% vs 8/43, 18.6%), MLH1 (2/38, 5.3% vs 5/43, 11.6%), and GNAS (1/38, 2.6% vs 5/43, 11.6%), compared with those in intrahepatic cholangiocarcinomas with normal liver.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP368757.RABrCyU9yAZIA_aVxu0MzsKKiU9ftfmQGqwwvT9ZY5gBE130_provenance.
- NP368757.RABrCyU9yAZIA_aVxu0MzsKKiU9ftfmQGqwwvT9ZY5gBE130_assertion evidence source_evidence_literature NP368757.RABrCyU9yAZIA_aVxu0MzsKKiU9ftfmQGqwwvT9ZY5gBE130_provenance.
- NP368757.RABrCyU9yAZIA_aVxu0MzsKKiU9ftfmQGqwwvT9ZY5gBE130_assertion SIO_000772 24186137 NP368757.RABrCyU9yAZIA_aVxu0MzsKKiU9ftfmQGqwwvT9ZY5gBE130_provenance.
- NP368757.RABrCyU9yAZIA_aVxu0MzsKKiU9ftfmQGqwwvT9ZY5gBE130_assertion wasDerivedFrom befree-20150227 NP368757.RABrCyU9yAZIA_aVxu0MzsKKiU9ftfmQGqwwvT9ZY5gBE130_provenance.
- NP368757.RABrCyU9yAZIA_aVxu0MzsKKiU9ftfmQGqwwvT9ZY5gBE130_assertion wasGeneratedBy ECO_0000203 NP368757.RABrCyU9yAZIA_aVxu0MzsKKiU9ftfmQGqwwvT9ZY5gBE130_provenance.
- befree-20150227 importedOn "2015-02-27" NP368757.RABrCyU9yAZIA_aVxu0MzsKKiU9ftfmQGqwwvT9ZY5gBE130_provenance.